Healthcare providers use Bendamustine in treating patients who have chronic lymphocytic leukemia and non-Hodgkin’s lymphoma. This drug comes in single-use vials in 100 mg to inject intravenously. The recommended dosage of Bendamustine is 100 mg/m2 administered intravenously over 10 minutes on Days 1 and 2 of a 28-day cycle, up to 6 cycles. Bendamustine is an alkylating agent.
Bendamustine injection 100 mg is readily available from several generic medicine suppliers. The Indian Pharma is an international supplier of generic drugs, supplying globally for more than 7 years.